Meng W - Search Results

1

Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoprotein.

Butterfield LH, Koh A, Meng W, Vollmer CM, Ribas A, Dissette V, Lee E, Glaspy JA, McBride WH, Economou JS. Butterfield LH, et al. Among authors: meng w. Cancer Res. 1999 Jul 1;59(13):3134-42. Cancer Res. 1999. PMID: 10397256

2

T-cell responses to HLA-A*0201 immunodominant peptides derived from alpha-fetoprotein in patients with hepatocellular cancer.

Butterfield LH, Ribas A, Meng WS, Dissette VB, Amarnani S, Vu HT, Seja E, Todd K, Glaspy JA, McBride WH, Economou JS. Butterfield LH, et al. Clin Cancer Res. 2003 Dec 1;9(16 Pt 1):5902-8. Clin Cancer Res. 2003. PMID: 14676113 Clinical Trial.

3

Fine specificity analysis of an HLA-A2.1-restricted immunodominant T cell epitope derived from human alpha-fetoprotein.

Meng WS, Butterfield LH, Ribas A, Heller JB, Dissette VB, Glaspy JA, McBride WH, Economou JS. Meng WS, et al. Mol Immunol. 2000 Nov;37(16):943-50. doi: 10.1016/s0161-5890(01)00017-7. Mol Immunol. 2000. PMID: 11395133

4

alpha-Fetoprotein-specific tumor immunity induced by plasmid prime-adenovirus boost genetic vaccination.

Meng WS, Butterfield LH, Ribas A, Dissette VB, Heller JB, Miranda GA, Glaspy JA, McBride WH, Economou JS. Meng WS, et al. Cancer Res. 2001 Dec 15;61(24):8782-6. Cancer Res. 2001. PMID: 11751399

5

CD40 cross-linking bypasses the absolute requirement for CD4 T cells during immunization with melanoma antigen gene-modified dendritic cells.

Ribas A, Butterfield LH, Amarnani SN, Dissette VB, Kim D, Meng WS, Miranda GA, Wang HJ, McBride WH, Glaspy JA, Economou JS. Ribas A, et al. Among authors: meng ws. Cancer Res. 2001 Dec 15;61(24):8787-93. Cancer Res. 2001. PMID: 11751400

6

Immune deviation and Fas-mediated deletion limit antitumor activity after multiple dendritic cell vaccinations in mice.

Ribas A, Butterfield LH, Hu B, Dissette VB, Meng WS, Koh A, Andrews KJ, Lee M, Amar SN, Glaspy JA, McBride WH, Economou JS. Ribas A, et al. Among authors: meng ws. Cancer Res. 2000 Apr 15;60(8):2218-24. Cancer Res. 2000. PMID: 10786687

7

T cell responses to HLA-A*0201-restricted peptides derived from human alpha fetoprotein.

Butterfield LH, Meng WS, Koh A, Vollmer CM, Ribas A, Dissette VB, Faull K, Glaspy JA, McBride WH, Economou JS. Butterfield LH, et al. Among authors: meng ws. J Immunol. 2001 Apr 15;166(8):5300-8. doi: 10.4049/jimmunol.166.8.5300. J Immunol. 2001. PMID: 11290817

8

Rational design of peptide-based tumor vaccines.

Meng WS, Butterfield LH. Meng WS, et al. Pharm Res. 2002 Jul;19(7):926-32. doi: 10.1023/a:1016497818471. Pharm Res. 2002. PMID: 12180543 Review.

9

Ionizing radiation affects human MART-1 melanoma antigen processing and presentation by dendritic cells.

Liao YP, Wang CC, Butterfield LH, Economou JS, Ribas A, Meng WS, Iwamoto KS, McBride WH. Liao YP, et al. J Immunol. 2004 Aug 15;173(4):2462-9. doi: 10.4049/jimmunol.173.4.2462. J Immunol. 2004. PMID: 15294960

10

Activation of antigen-presenting cells by DNA delivery vectors.

Meng WS, Butterfield LH. Meng WS, et al. Expert Opin Biol Ther. 2005 Aug;5(8):1019-28. doi: 10.1517/14712598.5.8.1019. Expert Opin Biol Ther. 2005. PMID: 16050780 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,922 results

Search Page

Filters